Skip to content

Study · Measured the body's own peptide · 2008

1 result

Increased plasma concentrations of cytoskeletal and Ca2+-binding proteins and their peptides in psoriasis patients.

Plavina T, Hincapie M, Wakshull E, Subramanyam M, Hancock WS

Clinical chemistry18 Sept 2008Cited by 35 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyMechanism

    In psoriasis patients, plasma concentrations of thymosin beta‑4 were increased compared with healthy donors.

    In plain wordsIn people with psoriasis, the body's own thymosin beta‑4 was linked to higher blood levels than in healthy donors.

    Outcome
    IncreasePlasma thymosin beta 4 concentration in psoriasis
    Study

    n = 40

    Comparator
    Matched healthy donors
    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    Among the increased proteins and peptides were thymosin beta 4, talin 1, actin gamma, filamin, and profilin.
    2 context sentences
    Summary · context
    One intriguing finding, increased concentrations of cytoskeletal and actin-binding proteins and their peptides in psoriatic plasma, suggested disease-related cell leakage of these proteins and their increased proteolysis.
    Summary · context
    We used 2 proteomic methods to analyze plasma samples from 20 psoriasis patients and 20 matched healthy donors.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.